Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABBR2 | O75899 | 1/20 | 0.48 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.45 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | ALB | P02768 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | PCSK7 | Q16549 | 1/20 | 0.44 |
| ▸ | VKORC1 | Q9BQB6 | 1/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.44 |
| ▸ | CCR5 | P51681 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13559962 | 0.90 | GABBR2 (0.53) | GABBR2GABBR1KDM4EALDH1A1MAPT | |
| SCHEMBL29110970 | 0.89 | PTGS2 (0.49) | ALDH1A1MAPTMEN1KMT2AFFAR1 | |
| SCHEMBL240789 | 0.86 | GABBR2 (0.66) | GABBR2GABBR1LMNAPOLBKDM4E | |
| SCHEMBL2484805 | 0.86 | GABBR2 (0.66) | GABBR2GABBR1LMNAPOLBKDM4E | |
| SCHEMBL6174106 | 0.86 | GABBR2 (0.66) | GABBR2GABBR1LMNAPOLBKDM4E | |
| SCHEMBL29110949 | 0.85 | L3MBTL1 (0.50) | FFAR1L3MBTL1 | |
| SCHEMBL6722503 | 0.84 | GABBR2 (0.48) | GABBR2GABBR1LMNAPOLBMAPT | |
| SCHEMBL4445085 | 0.84 | GABBR2 (0.48) | GABBR2GABBR1KDM4EALDH1A1MAPT | |
| SCHEMBL9857550 | 0.84 | GABBR2 (0.63) | GABBR2GABBR1POLBKDM4EALDH1A1 | |
| SCHEMBL17877672 | 0.82 | GABBR2 (0.47) | GABBR2GABBR1LMNAPOLBKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115297728-A | Agrochemical compositions of triazoles | 阿达玛马克西姆有限公司 | 2022-11-04 | — | — | CN | claimed |
| CN-116655459-B | Synthetic method for selectively synthesizing 4-aryl-2-hexanone | 河南大学 | 2025-05-09 | — | — | CN | disclosed |
| CN-116655459-A | Synthetic method for selectively synthesizing 4-aryl-2-hexanone | 河南大学 | 2023-08-29 | — | — | CN | disclosed |
| CN-115297728-A | Agrochemical compositions of triazoles | 阿达玛马克西姆有限公司 | 2022-11-04 | — | — | CN | disclosed |
| EP-2242760-B1 | SULFONATED ORGANOPHOSPHINE COMPOUNDS AND USE IN HYDROFORMYLATION PROCESSES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2014-03-05 | — | — | EP | disclosed |
| US-8466306-B2 | Sulfonated organophosphine compounds and use in hydroformylation processes | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-06-18 | — | — | US | disclosed |
| US-20110054203-A1 | SULFONATED ORGANOPHOSPHINE COMPOUNDS AND USE IN HYDROFORMYLATION PROCESSES | DOW GLOBAL TECHNOLOGIES INC. (US) | 2011-03-03 | — | — | US | disclosed |
| EP-2242760-A1 | SULFONATED ORGANOPHOSPHINE COMPOUNDS AND USE IN HYDROFORMYLATION PROCESSES | Dow Global Technologies Inc. (US) | 2010-10-27 | — | — | EP | disclosed |
| WO-2009091669-A1 | SULFONATED ORGANOPHOSPHINE COMPOUNDS AND USE IN HYDROFORMYLATION PROCESSES | DOW GLOBAL TECHNOLOGIES INC. (US) | 2009-07-23 | — | — | WO | disclosed |
| CN-100400523-C | Substituted piperazines, (1,4) diaza * class and 2, 5-diazabicyclo (2.2.1) heptanes as histamine H1 and/or H3 antagonists or histamine H3 reverse antagonists | GLAXO GROUP LTD (GB) | 2008-07-09 | — | — | CN | disclosed |
| US-5932771-A | PERFUMES | SMITHKLINE BEECHAM CORPORATION (US) | 1999-08-03 | — | — | US | disclosed |
| US-5908944-A | COPPER COMPOUND CATALYST | SCHERING AKTIENGESELLSCHAFT (DE) | 1999-06-01 | — | — | US | disclosed |
| US-5908945-A | COPPER COMPOUND AND SILYL REAGENT AS CATALYSTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1999-06-01 | — | — | US | disclosed |
| EP-0863864-A1 | CARBONYL COMPOUNDS | Henkel Kommanditgesellschaft auf Aktien (DE) | 1998-09-16 | — | — | EP | disclosed |
| WO-1997017314-A1 | CARBONYL COMPOUNDS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1997-05-15 | — | — | WO | disclosed |
| EP-0691974-B1 | ALKYLATING AGENT AND 1,4-ADDITION PROCESS OF AN ALKYL GROUP ONTO AN ALPHA, BETA-UNSATURATED KETONE COMPOUND | SCHERING AG (DE) | 1997-05-07 | — | — | EP | disclosed |
| EP-0534582-B1 | Methylation or ethylation agent and process for an 1,4-addition of a methyl- or ethylgroup to an alpha, beta-insaturated ketogroup | SCHERING AG (DE) | 1997-01-08 | — | — | EP | disclosed |
| WO-1996039371-A1 | AROMATIC CARBONYL COMPOUNDS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1996-12-12 | — | — | WO | disclosed |
| WO-1993006066-A1 | METHYLATING OR ETHYLATING AGENT AND PROCESS FOR 1,4-ADDING A METHYL OR ETHYL GROUP TO AN α,β-UNSATURATED KETO COMPOUND __ | SCHERING AKTIENGESELLSCHAFT (DE) | 1993-04-01 | — | — | WO | disclosed |
| EP-0534582-A1 | Methylation or ethylation agent and process for an 1,4-addition of a methyl- or ethylgroup to an alpha, beta-insaturated ketogroup | SCHERING AKTIENGESELLSCHAFT (DE) | 1993-03-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110054203-A1 | SULFONATED ORGANOPHOSPHINE COMPOUNDS AND USE IN HYDROFORMYLATION PROCESSES | ORMDL3, IP6K3, ALK | GABBR2 4332/4885GABBR1 4329/4885LMNA 4629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.